Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Herbalife International 1995 net sales up 4.7% to $489 mil.; profits fall 57.1% to $19.7 mil.

This article was originally published in The Tan Sheet

Executive Summary

HERBALIFE 1995 RETAIL SALES INCREASE 4.5% to $884.1 mil., reflecting sales growth in the U.S., Japan, Brazil and Russia, expansion into new markets, such as Argentina and Venezuela, and the launch of a new personal care line, which contributed more than $100 mil. to annual sales. However, lower sales in some countries and currency exchange rates offset some of the positive influences, Herbalife International noted

You may also be interested in...



QUOTED. 2 April 2020. Chris Whitty.

UK public health officials said recently that COVID-19 self-tests may soon be available to buy through Amazon or pharmacies. Here’s what Chris Whitty, Chief Medical Adviser to the UK government, said about the proposal.

Neurology At The Forefront Of US FDA Complex Innovative Trial Design Pilot

Wave’s Duchenne muscular dystrophy drug and Lilly’s chronic pain R&D will test the agency’s CID meeting pilot program, while FDA issues draft guidance that highlights potential uses for complex innovative trial designs.

US FDA And Sponsors Resolve Disclosure Issues On Complex Trial Design Pilot Projects

Agency officials can now discuss the ideas that have been accepted, though not in great detail.

Topics

UsernamePublicRestriction

Register

PS084788

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel